Free Trial
TSE:ATE

Antibe Therapeutics (ATE) Stock Price, News & Analysis

Antibe Therapeutics logo

About Antibe Therapeutics Stock (TSE:ATE)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
167,044 shs
Average Volume
135,475 shs
Market Capitalization
C$15.64 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ATE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Antibe Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

ATE Stock News Headlines

A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
Antibe Extends Early Warrant Exercise Incentive Program
Antibe Therapeutics Inc ATE
Antibe Announces Early Warrant Exercise Incentive Program
See More Headlines

ATE Stock Analysis - Frequently Asked Questions

Shares of ATE stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Antibe Therapeutics investors own include Resverlogix (RVX), Royal Bank of Canada (RY), Tesla (TSLA), Unrivaled Brands (TRTC), Baytex Energy (BTE), Enbridge (ENB) and NVIDIA (NVDA).

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
TSE:ATE
CIK
N/A
Fax
N/A
Employees
11
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.35)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$18.24 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-52.72%
Return on Assets
-19.13%

Debt

Debt-to-Equity Ratio
0.29
Current Ratio
10.06
Quick Ratio
9.58

Sales & Book Value

Annual Sales
C$9.71 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
0.61
Book Value
C$0.49 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
53,010,000
Free Float
N/A
Market Cap
C$15.64 million
Optionable
Not Optionable
Beta
0.19
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (TSE:ATE) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners